Advanced search
Show most relevant results first | Most recent results are first | Show use by person

Search only Cormac DevlinSearch all speeches

Results 221-240 of 4,486 for speaker:Cormac Devlin

Written Answers — Department of Health: Departmental Bodies (8 Sep 2025)

Cormac Devlin: 2680. To ask the Minister for Health the basis for the delineation of practice whereby counsellors are trained to work with mild to moderate presentations while psychotherapists are trained for moderate to severe and complex presentations in the Standards of Proficiency adopted in July 2025; if she will provide the workforce and access to care impact assessment underpinning this delineation;...

Written Answers — Department of Health: Departmental Data (8 Sep 2025)

Cormac Devlin: 2080. To ask the Minister for Health the number of advance healthcare directives submitted to the Decision Support Service, by month since April 2023; the number of decisions made each month in respect of such submissions, including any refusals, in tabular form; and if she will make a statement on the matter. [44615/25]

Written Answers — Department of Health: Organ Donation (8 Sep 2025)

Cormac Devlin: 2200. To ask the Minister for Health if she is aware of an issue in relation to the organ donation opt-out register (details supplied); and if she will make a statement on the matter. [45044/25]

Written Answers — Department of Health: Organ Donation (8 Sep 2025)

Cormac Devlin: 2201. To ask the Minister for Health to provide an update on the number of applications processed by the new organ donation opt-out register system, by month, in tabular form; and if she will make a statement on the matter. [45045/25]

Written Answers — Department of Health: Organ Donation (8 Sep 2025)

Cormac Devlin: 2202. To ask the Minister for Health to provide an update on the number of complaints received by the HSE in relation to the new organ donation opt-out register system, by month, in tabular form; if a manual mechanism will be created to allow individuals opt out where the system fails to record their preference; and if she will make a statement on the matter. [45046/25]

Written Answers — Department of Health: Medicinal Products (8 Sep 2025)

Cormac Devlin: 2618. To ask the Minister for Health if she will provide an update on the NCPE appraisal of ritlecitinib (litfulo) for severe alopecia areata, including current stage, any ongoing HSE pricing and reimbursement engagement with the applicant; the expected timelines for a decision and proposed prescribing setting if approved; and if she will make a statement on the matter. [46999/25]

Written Answers — Department of Health: Medicinal Products (8 Sep 2025)

Cormac Devlin: 2619. To ask the Minister for Health if an application has been received by the HSE for pricing and reimbursement of baricitinib for the alopecia areata indication; if not, if the HSE or her Department has engaged with the marketing authorisation holder regarding a submission; and if she will make a statement on the matter. [47000/25]

Written Answers — Department of Health: Medicinal Products (8 Sep 2025)

Cormac Devlin: 2620. To ask the Minister for Health if her Department, the HSE or the HPRA has engaged with the manufacturer of deuruxolitinib (leqselvi) regarding plans for EU submission and availability in Ireland; if any named-patient or compassionate access requests have been received; and if she will make a statement on the matter. [47001/25]

Written Answers — Department of Health: Health Services (8 Sep 2025)

Cormac Devlin: 2621. To ask the Minister for Health if JAK inhibitor treatments for severe alopecia areata, where reimbursed will be provided via the high tech arrangement; the intended initiation and monitoring setting; the proposed stop rules; the estimated annual budget impact and eligible patient numbers; and if she will make a statement on the matter. [47002/25]

Written Answers — Department of Health: Departmental Data (8 Sep 2025)

Cormac Devlin: 2622. To ask the Minister for Health the number of patients treated for alopecia areata with JAK inhibitors in public hospitals in each of the past three years, by CHO and by medicine, including any named-patient access, and associated monitoring protocols; and if she will make a statement on the matter. [47003/25]

Written Answers — Department of Health: Health Strategies (8 Sep 2025)

Cormac Devlin: 2623. To ask the Minister for Health if she will publish a national clinical pathway for alopecia areata within the HSE Model of Care for Dermatology (details supplied); and if she will make a statement on the matter. [47004/25]

Written Answers — Department of Health: Departmental Data (8 Sep 2025)

Cormac Devlin: 2624. To ask the Minister for Health the number of public dermatology centres that provide topical immunotherapy for example DPCP or SADBE for extensive alopecia areata; the number treated in each of the past three years; the average waiting times; if capacity expansion is planned; and if she will make a statement on the matter. [47005/25]

Written Answers — Department of Health: Departmental Data (8 Sep 2025)

Cormac Devlin: 2625. To ask the Minister for Health the details of the availability of intralesional corticosteroid clinics for patchy alopecia areata, by hospital group; the average wait time from referral; the actions to standardise access nationally; and if she will make a statement on the matter. [47006/25]

Written Answers — Department of Health: Health Services (8 Sep 2025)

Cormac Devlin: 2626. To ask the Minister for Health if the HSE will establish a national registry to capture outcomes for alopecia areata (details supplied); the proposed data controller and governance; the expected start date; and if she will make a statement on the matter. [47007/25]

Written Answers — Department of Health: Health Strategies (8 Sep 2025)

Cormac Devlin: 2627. To ask the Minister for Health if she will issue guidance on vaccination including the shingles vaccination and infection-risk mitigation for patients commencing JAK inhibitors for alopecia areata, including funding and delivery arrangements; and if she will make a statement on the matter. [47008/25]

Written Answers — Department of Health: Healthcare Policy (8 Sep 2025)

Cormac Devlin: 2628. To ask the Minister for Health for Ireland’s position on the amendments to the international health regulations adopted by the World Health Assembly on 1 June 2024; if Ireland has lodged any reservation or objection to the amendments with the World Health Organisation; the timeline for the Government’s consideration of the amendments; the details around the impact of the...

Written Answers — Department of Health: Health Services (8 Sep 2025)

Cormac Devlin: 2629. To ask the Minister for Health if she will clarify the eligibility of dermatology outpatient consultations for alopecia areata under the Cross-Border Healthcare Directive; the documentation required; whether take-home medicinal products prescribed abroad for alopecia areata are reimbursable under the CBD scheme; and if she will make a statement on the matter. [47014/25]

Written Answers — Department of Health: Departmental Data (8 Sep 2025)

Cormac Devlin: 2630. To ask the Minister for Health the number of dermatology referrals for alopecia areata supported by the national treatment purchase fund (NTPF) in each of the past three years; the median and 95th percentile waits before and after NTPF intervention; and if she will make a statement on the matter. [47015/25]

Written Answers — Department of Health: Health Services (8 Sep 2025)

Cormac Devlin: 2631. To ask the Minister for Health if she will ensure access to psychological support services for patients with visible hair loss conditions, including alopecia areata and scarring alopecias; the referral pathway from dermatology clinics; the planned service improvements; and if she will make a statement on the matter. [47016/25]

Written Answers — Department of Health: Departmental Programmes (8 Sep 2025)

Cormac Devlin: 2632. To ask the Minister for Health if the HSE medicines management programme will include alopecia areata therapies in its horizon-scanning outputs and publish periodic patient friendly updates on access status for new treatments; and if she will make a statement on the matter. [47017/25]

   Advanced search
Show most relevant results first | Most recent results are first | Show use by person

Search only Cormac DevlinSearch all speeches